Cytosorbents Corp Files 8-K on Financials
Ticker: CTSO · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Cytosorbents dropped an 8-K detailing their financials - check it for the latest numbers.
AI Summary
Cytosorbents Corporation filed an 8-K on March 4, 2025, reporting on its results of operations and financial condition, as well as providing Regulation FD disclosures and financial statements. The filing details the company's financial performance and related disclosures.
Why It Matters
This filing provides crucial updates on Cytosorbents' financial health and operational results, which are important for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not appear to contain any immediately alarming or significant new risks.
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- March 4, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of incorporation
- 001-36792 (commission_file_number) — SEC File Number
- 98-0373793 (irs_number) — I.R.S. Employer Identification No.
- 305 College Road East Princeton, New Jersey 08540 (address) — Principal executive offices
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.
What is the primary purpose of this 8-K filing?
The primary purpose is to report on the company's results of operations and financial condition, provide Regulation FD disclosures, and include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on March 4, 2025.
What is Cytosorbents Corporation's state of incorporation?
Cytosorbents Corporation is incorporated in Delaware.
Where are Cytosorbents Corporation's principal executive offices located?
The principal executive offices are located at 305 College Road East, Princeton, New Jersey 08540.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding Cytosorbents Corp (CTSO).